JUL 16, 2020 10:00 AM PDT

Implications of Rapid IDH1/IDH2 Testing for Liquid and Solid Tumors

Speaker

Abstract

DATE: July 16, 2020

TIME:  10:00 am PDT

 

This seminar reviews clinical utility of adopting rapid IDH1/2 testing in both hematological and solid tumors and describes the adjusted workflow developed. Isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) are enzymes involved in cellular metabolism and cellular differentiation. Mutations in the IDH1 and IDH2 genes alter their enzymatic activity to produce an oncometabolite. Disease-associated variants in IDH1/2 have clinical implications for multiple forms of cancer. Molecular detection of IDH1 and IDH2 disease-associated variants aids in diagnosis, prognostic stratification, and treatment decisions. For example, detection of IDH variants in acute myeloid leukemia (AML) allows for the addition of IDH-targeted therapies to treatment regimens. Additionally, the diagnosis and prognosis of gliomas are dependent on the IDH1/2 molecular status. In these ways, it is increasingly important to have rapid molecular testing for IDH1/2. Challenges of implementing IDH testing include redundant testing (immunohistochemistry and massively parallel sequencing) and limited specimen material. In order to address these challenges, the clinical utility of rapid IDH1/2 testing was evaluated and modifications to the laboratory workflow were explored. These studies highlight the value of rapid IDH testing and show that procedural adjustments can both streamline laboratory workflows and conserve vital limited specimen material. 

 

Learning Objectives:

  • Understand the clinical utility of rapid IDH1/2 testing in hematologic neoplasms 
  • Recognize how rapid molecular IDH1/2 testing can aid in the diagnosis of solid tumors 
  • Identify workflow modifications that allow for efficient use of specimens 

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
OCT 12, 2022 8:00 AM PDT
OCT 12, 2022 8:00 AM PDT
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
Loading Comments...
Show Resources